Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT06603285
A Study to Observe the Safety, Tolerability, and Efficacy of Remodulin
Sponsor: Excelsior
View on ClinicalTrials.gov
Summary
This is a multi-center, single-arm, prospective study to enroll patients diagnosed as pulmonary arterial hypertension. The objective in this study is to observe the efficacy and safety of treprostinil in subjects with pulmonary arterial hypertension.
Official title: A Multi-center, Prospective Study to Observe the Safety, Tolerability, and Efficacy of Remodulin® in Patients With Pulmonary Arterial Hypertension
Key Details
Gender
All
Age Range
Any - Any
Study Type
OBSERVATIONAL
Enrollment
20
Start Date
2025-10-16
Completion Date
2029-12-31
Last Updated
2025-08-15
Healthy Volunteers
No
Conditions
Interventions
DRUG
Treprostinil
sc/iv continuously